Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
immunotherapy modeling is highly desirable, candidates with the following experience will also be considered: stem cell-derived organoid models (specifically brain, lung, or tumor organoids), lab-on-chip
-
-activated cell sorting (FACS), and immunoprecipitation (IP). Maintains and differentiates human induced pluripotent stem cells (iPSCs) into specific cell lineages using established protocols and assist with
-
Hematopoietic stem and progenitor cells (HSPCs) constitute a rare yet indispensable population within the bone marrow that sustains lifelong blood cell production. Preservation of their integrity and functional
-
for this postdoctoral study focuses on two stages of processing. The first stage is retting, where the candidate will study the physicochemical properties (evolution of the primary and secondary cell walls of the stems
-
and malignant stem cells in the context of aging and cancer. As an NCI-designated Comprehensive Cancer Center, the Stanford Cancer Institute is a dynamic and stimulating place to work as it maintains
-
these receptors, to become therapies against cancer stem cell-driven relapse and metastasis. Furthermore, the DCs in the network will devise pre-formulation strategies for the compounds and develop a novel, deep
-
doctoral degree such as MD or PhD or equivalent degree and has interests in immunotherapy and/or hematopoietic stem cell transplantation using mouse animal models. The research involves understanding
-
and contribute to funding applications. QUALIFICATIONS Successful applicants will have: A PhD in biology, genetics, or related field. Strong background in wet lab techniques, with an emphasis on cell
-
of specific DNA repeats. We are seeking motivated candidate who has experience in the following aspects: Biology of C. elegans; cell culture particularly induced pluripotent stem cells and neurons; recombinant
-
Stem cell therapies offer a new therapeutic paradigm in regenerative medicine. Bioengineering approaches can help to deliver specialised cells targeting specific clinical challenges, yet there